Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Hydroxyprogesterone caproate is a synthetic progestogen.1 In vivo, hydroxyprogesterone caproate (3.32 mg/kg) reduces TNF-α-induced hypertension and decreases renal endothelin-1 (ET-1) production in pregnant rats. It reduces hypertension and production of TNF-α and IL-6 induced by reduction in uteroplacental perfusion (RUPP) in pregnant rats.2 Hydroxyprogesterone caproate also prevents preterm birth induced by L-NAME (Item No. 80210) in pregnant mice.3 Formulations containing hydroxyprogesterone caproate have been used for the prevention of preterm birth.
WARNING This product is not for human or veterinary use.
1. Effects of 17-
2. 17-
3. Progestational agents prevent preterm birth induced by a nitric oxide synthesis inhibitor in the mouse. In Vivo 22(4), 447-450 (2008).